Celexa is the SSRI (selective serotonin reuptake inhibitor, the standard first-line antidepressant class that boosts serotonin without much else going on)…
Sections
Celexa is the SSRI (selective serotonin reuptake inhibitor, the standard first-line antidepressant class that boosts serotonin without much else going on) I think of as the workhorse of the workhorses. Nothing particularly exciting about it, which is most of the reason I like it. It’s been around since the late 1990s, the data is solid, the side effect profile is predictable, and it’s almost free in generic. For a lot of guys coming in with their first depressive or anxiety episode, Celexa is a fine first pick, and not picking it usually means there’s a specific reason to pick something else.
If we’re being honest, the conversation patients want to have about Celexa is usually “is this the gentle one or the harsh one.” It’s the gentle one. As gentle as SSRIs get. That doesn’t mean side-effect-free, no antidepressant is, it means the side effect picture is the most boring and the most predictable in the class, which is exactly what you want from a first-line med.
What it does
Citalopram is, as advertised, a selective serotonin reuptake inhibitor. It’s about as clean as SSRIs come, it doesn’t hit much besides the serotonin transporter, which means fewer off-target effects than older agents. It’s FDA-approved for depression and used widely off-label for anxiety, panic, OCD (obsessive-compulsive disorder, the intrusive-thoughts-and-rituals condition), and PTSD (post-traumatic stress disorder). For the average uncomplicated first-line case, Celexa or its enantiomer Lexapro (escitalopram, basically the cleaner half of the citalopram molecule) is what most psychiatrists are reaching for.
The mechanism is the same as every other SSRI. Block serotonin reuptake at the presynaptic transporter, more serotonin sticks around in the synapse, the receiving neuron gets more signal, and after about four to six weeks the downstream changes in the brain start to add up to something the patient can actually feel. The “chemical imbalance” framing that got popularized in the 1990s is a simplification of a simplification, what’s actually happening is a slow restructuring of how the receiving neurons respond, and the first month is mostly the lag while that restructuring is in progress. None of which the patient needs to know, but knowing it explains why nothing seems to be happening for the first three weeks and why quitting at week two is the most common reason an SSRI trial “fails.”
The QT prolongation cap
The one thing that makes Celexa different from the other SSRIs is the FDA dose cap. Back in 2011, the FDA warned that citalopram doses above 40mg per day (or 20mg in patients over 60 or with liver problems) shouldn’t be used because of QT prolongation, which is a heart-rhythm issue where the electrical reset between heartbeats takes a little longer than normal. In rare cases that can set up a dangerous arrhythmia called torsades de pointes, which is as scary as it sounds, the heart rhythm going chaotic and potentially leading to cardiac arrest. The FDA warning is built in to keep the rare bad outcomes from happening.
That cap is real and most prescribers follow it. If you’re on 40mg and still not at remission, the move is usually to switch agents or augment with a second drug, not to push higher. Lexapro doesn’t have the same cap and goes up to 20mg in standard dosing, which is roughly equivalent to 40mg of Celexa, which is most of why Lexapro has taken over as the more commonly prescribed of the two over the last fifteen years.
For most patients the QT issue is theoretical. If you don’t have a baseline heart condition, aren’t on other QT-prolonging meds, don’t have your electrolytes out of whack, and aren’t elderly, the actual cardiac risk on standard-dose Celexa is very low. The dose cap is the conservative guardrail. Patients who freak out about the QT warning after Googling it usually need the reassurance that the warning exists for a small subset of patients and isn’t really about the 35-year-old healthy guy on 20mg.
When to pick Celexa
First-line uncomplicated depression or anxiety in a patient who’s not on a lot of other medications. The price tag for generic Celexa is essentially nothing, which matters for patients on a tight budget or without good insurance coverage. The half-life is moderate (about 35 hours, which is forgiving of occasional missed doses without the brain-zaps experience of Effexor or Paxil), and the drug interaction profile is one of the cleanest in the SSRI class, which matters for patients on multiple meds for other conditions.
It’s also a reasonable choice for older patients, with the caveat about the 20mg cap. The cleaner interaction profile is helpful when you’re worried about adding to a complicated medication regimen, the kind of regimen guys in their sixties often already have for blood pressure and cholesterol and reflux. Adding Celexa to that picture is less likely to bump into something else than adding Paxil would be.
When Celexa isn’t the pick: patients with known cardiac issues, patients on other QT-prolonging meds (some antibiotics, some antipsychotics, methadone), patients who’ve already failed citalopram or escitalopram in the past, patients whose anxiety is severe enough that Lexapro’s slightly faster onset is worth reaching for. Patients with a specific reason to want Wellbutrin (which doesn’t tank libido or cause weight gain) over an SSRI also get talked out of Celexa as the first move. The drug is right for the right patient, not for everyone.
The starting dose and titration
Most adults start on 20mg once daily, which is the average effective dose. Some prescribers start at 10mg for a week before going up to 20, particularly for patients who are sensitive to side effects or have a lot of anxiety on top of the depression. Side effects in the first one to two weeks are the usual SSRI suite: GI stuff, headache, occasional jitteriness, sometimes sleep disruption either direction. Most settle by week three.
If 20mg isn’t enough after six to eight weeks of full adherence, the move is to 40mg or to switch agents. Sexual side effects show up in about 25 to 35 percent of patients and are usually delayed onset (taking longer to finish), reduced libido, and occasional erection issues. Those are the side effects most patients are weighing against the benefit, and the conversation about whether the trade is worth it is one we have a lot. For a patient who’s been depressed for two years and getting his life back, three months in he’s often willing to live with a delayed orgasm. For a patient who’s already worried about his sex life, that side effect is going to be the dealbreaker. Both of those are reasonable positions and the choice is the patient’s, not the prescriber’s.
Sexual side effects, the actual conversation
I’ll be direct about this because most appointments aren’t. The nuts not working like they used to is one of the more common reasons guys quit SSRIs without telling anyone. If it’s happening, say so. The fix isn’t always switching the drug. Sometimes it’s adding bupropion (Wellbutrin) at 150mg in the morning, which has data for reversing the sexual side effects of SSRIs and doesn’t tank mood. Sometimes it’s switching to Trintellix or Wellbutrin entirely. Sometimes it’s waiting another month because the side effect resolves on its own for some patients. The version where you quietly stop the med and tell nobody is the version that ends up with a depression relapse three months later that nobody saw coming.
The patient autonomy piece
If you want Celexa and you’ve heard the honest take, the answer is yes. If you want to try Lexapro instead, the answer is also yes. If you don’t want an SSRI at all and want to try Wellbutrin first because you’ve heard it doesn’t mess with libido, the answer is yes to that too. Provider, not parent. Disapproving yes for the cases where I’d have picked something different, but yes regardless. The appointment isn’t mine, it’s yours, and I hardly ever say no. The honest take is what I’m here for. The choice is yours.
What’s nice to hear
Celexa or Lexapro for a single discrete depressive or anxious episode is one of the cleaner stories in psychiatry. Start, climb to a working dose over a couple of weeks, hit week six feeling meaningfully better, stay on for twelve to eighteen months, taper off, done. That story plays out for a meaningful percentage of patients on this drug, and it’s worth saying out loud because most of the writing about SSRIs is about the people for whom they didn’t work or the side effects were dealbreakers. For the majority of patients with a first depressive episode without complications, the drug works, the side effects are tolerable, and the eventual taper is uneventful. That isn’t a marketing line, it’s the boring version of the story that doesn’t get written up.
The kind of guy who comes in with what looks like a clean first major depressive episode, no real prior history, brought on by a year of unusual stress at work after a corporate restructuring, sleeping fine but waking up tired, having lost interest in stuff he used to enjoy, whose wife told him she missed the guy he used to be… starts 20mg, has a couple of weeks of nausea and headache, hits week six sleeping better with his energy back, hits week ten with his wife telling him she has her husband back, stays on for fourteen months, tapers over three months, fine. Three years later he hasn’t been back. That’s the version most patients want and most patients on Celexa for a single episode actually get a version of.
Celexa is the workhorse of the workhorses. Nothing particularly exciting about it, which is most of the reason I like it.
Bottom line
Celexa is a fine first SSRI for most uncomplicated cases of depression or anxiety. The 40mg cap is real but mostly irrelevant if you don’t have cardiac issues. It’s cheap, predictable, and well-tolerated by most patients. If 40mg isn’t getting you there, the next move is a switch, not a push to a higher dose. And if you’re starting your first antidepressant and your prescriber suggests Celexa or Lexapro, that’s a reasonable place to start, not a sign that they’re not trying hard enough. Boring is a feature, not a bug.
The thing nobody puts on the marketing material is that the medications that quietly do their job rarely get any attention, because nothing dramatic happens. The patient gets a little better over six weeks, stays better, eventually comes off, and never has a Reddit thread about it. That’s the version you want. Celexa hands more patients that version than almost any other SSRI in the catalog, and that’s the case for picking it without overthinking it.
Sources
- U.S. Food and Drug Administration. Celexa (citalopram hydrobromide) Prescribing Information. NDA 020822. FDA; 2024. FDA label.
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–1366. PMID 29477251.
- Yin J, Song X, Wang C, Lin X, Miao M. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2023;23(1):876. PMID 38001423.
